Outcomes of Transjugular Intrahepatic Portosystemic Shunts for Ascites

 

 Buy Article Permissions and Reprints

Abstract

Refractory ascites represents a devastating complication of portal hypertension. Transjugular intrahepatic portosystemic shunt (TIPS) is an efficacious option for patients for whom transplant is not an immediate option. Techniques to optimize the hepatic venous pressure gradient and the use of covered stents have reduced rates of hepatic encephalopathy and stent occlusion, respectively. Patients with a Model for End-Stage Liver Disease score less than 15, serum creatinine less than 2 mg/dL, and serum bilirubin less than 2 mg/dL are particularly suited for TIPS placement. TIPS is also effective for hepatic hydrothorax and for massive ascites in the posttransplant setting, although future investigations are necessary to elucidate risk factors and establish the effect on transplant-free survival.

• References

• 1 Cichoz-Lach H, Celiński K, Słomka M, Kasztelan-Szczerbińska B. Pathophysiology of portal hypertension. J Physiol Pharmacol 2008; 59 (Suppl. 02) 231-238
  PubMedGoogle Scholar
• 2 de Franchis R ; Baveno V Faculty. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2010; 53 (4) 762-768
  CrossrefPubMedGoogle Scholar
• 3 de Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2005; 43 (1) 167-176
  CrossrefPubMedGoogle Scholar
• 4 D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 2006; 44 (1) 217-231
  CrossrefPubMedGoogle Scholar
• 5 Garcia-Tsao G, Sanyal AJ, Grace ND, Carey W ; Practice Guidelines Committee of the American Association for the Study of Liver Diseases; Practice Parameters Committee of the American College of Gastroenterology. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology 2007; 46 (3) 922-938
  CrossrefPubMedGoogle Scholar
• 6 Garcia-Tsao G, Sanyal AJ, Grace ND, Carey WD ; Practice Guidelines Committee of American Association for Study of Liver Diseases; Practice Parameters Committee of American College of Gastroenterology. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Am J Gastroenterol 2007; 102 (9) 2086-2102
  CrossrefPubMedGoogle Scholar
• 7 Tsai MH. Splanchnic and systemic vasodilatation: the patient. J Clin Gastroenterol 2007; 41 (Suppl. 03) S266-S271
  CrossrefPubMedGoogle Scholar
• 8 Dib N, Oberti F, Calès P. Current management of the complications of portal hypertension: variceal bleeding and ascites. CMAJ 2006; 174 (10) 1433-1443
  CrossrefPubMedGoogle Scholar
• 9 Garcia-Tsao G. Current management of the complications of cirrhosis and portal hypertension: variceal hemorrhage, ascites, and spontaneous bacterial peritonitis. Gastroenterology 2001; 120 (3) 726-748
  CrossrefPubMedGoogle Scholar
• 10 Arroyo V, Rodés J. A rational approach to the treatment of ascites. Postgrad Med J 1975; 51 (598) 558-562
  CrossrefPubMedGoogle Scholar
• 11 Khungar V, Saab S. Cirrhosis with refractory ascites: serial large volume paracentesis, TIPS, or transplantation?. Clin Gastroenterol Hepatol 2011; 9 (11) 931-935 , quiz e121–e122
  CrossrefPubMedGoogle Scholar
• 12 Owen AR, Stanley AJ, Vijayananthan A, Moss JG. The transjugular intrahepatic portosystemic shunt (TIPS). Clin Radiol 2009; 64 (7) 664-674
  CrossrefPubMedGoogle Scholar
• 13 Ginés P, Quintero E, Arroyo V , et al. Compensated cirrhosis: natural history and prognostic factors. Hepatology 1987; 7 (1) 122-128
  CrossrefPubMedGoogle Scholar
• 14 Arroyo V, Ginès A, Saló J. A European survey on the treatment of ascites in cirrhosis. J Hepatol 1994; 21 (4) 667-672
  CrossrefPubMedGoogle Scholar
• 15 Garcia N, Sanyal AJ. Ascites. Curr Treat Options Gastroenterol 2001; 4 (6) 527-537
  CrossrefPubMedGoogle Scholar
• 16 Zipprich A, Garcia-Tsao G, Rogowski S, Fleig WE, Seufferlein T, Dollinger MM. Prognostic indicators of survival in patients with compensated and decompensated cirrhosis. Liver Int 2012; 32 (9) 1407-1414
  CrossrefPubMedGoogle Scholar
• 17 Weinstein MP, Iannini PB, Stratton CW, Eickhoff TC. Spontaneous bacterial peritonitis. A review of 28 cases with emphasis on improved survival and factors influencing prognosis. Am J Med 1978; 64 (4) 592-598
  CrossrefPubMedGoogle Scholar
• 18 Moore KP, Wong F, Gines P , et al. The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology 2003; 38 (1) 258-266
  PubMedGoogle Scholar
• 19 Senousy BE, Draganov PV. Evaluation and management of patients with refractory ascites. World J Gastroenterol 2009; 15 (1) 67-80
  CrossrefPubMedGoogle Scholar
• 20 Rössle M, Gerbes AL. TIPS for the treatment of refractory ascites, hepatorenal syndrome and hepatic hydrothorax: a critical update. Gut 2010; 59 (7) 988-1000
  CrossrefPubMedGoogle Scholar
• 21 Russo MW, Sood A, Jacobson IM, Brown Jr RS. Transjugular intrahepatic portosystemic shunt for refractory ascites: an analysis of the literature on efficacy, morbidity, and mortality. Am J Gastroenterol 2003; 98 (11) 2521-2527
  CrossrefPubMedGoogle Scholar
• 22 Ginès P, Uriz J, Calahorra B , et al. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis. Gastroenterology 2002; 123 (6) 1839-1847
  CrossrefPubMedGoogle Scholar
• 23 Boyer TD. Transjugular intrahepatic portosystemic shunt in the management of complications of portal hypertension. Curr Gastroenterol Rep 2008; 10 (1) 30-35
  CrossrefPubMedGoogle Scholar
• 24 Busk TM, Bendtsen F, Møller S. Cardiac and renal effects of a transjugular intrahepatic portosystemic shunt in cirrhosis. Eur J Gastroenterol Hepatol 2013; 25 (5) 523-530
  CrossrefPubMedGoogle Scholar
• 25 Garcia-Tsao G. Transjugular intrahepatic portosystemic shunt in the management of refractory ascites. Semin Intervent Radiol 2005; 22 (4) 278-286
  Article in Thieme ConnectPubMedGoogle Scholar
• 26 LaBerge JM. Transjugular intrahepatic portosystemic shunt—role in treating intractable variceal bleeding, ascites, and hepatic hydrothorax. Clin Liver Dis 2006; 10 (3) 583-598 , ix
  CrossrefPubMedGoogle Scholar
• 27 Narahara Y, Kanazawa H, Fukuda T , et al. Transjugular intrahepatic portosystemic shunt versus paracentesis plus albumin in patients with refractory ascites who have good hepatic and renal function: a prospective randomized trial. J Gastroenterol 2011; 46 (1) 78-85
  CrossrefPubMedGoogle Scholar
• 28 Saab S, Nieto JM, Lewis SK, Runyon BA. TIPS versus paracentesis for cirrhotic patients with refractory ascites. Cochrane Database Syst Rev 2006; CD004889
  PubMedGoogle Scholar
• 29 Salerno F, Cammà C, Enea M, Rössle M, Wong F. Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patient data. Gastroenterology 2007; 133 (3) 825-834
  CrossrefPubMedGoogle Scholar
• 30 Albillos A, Bañares R, González M, Catalina MV, Molinero LM. A meta-analysis of transjugular intrahepatic portosystemic shunt versus paracentesis for refractory ascites. J Hepatol 2005; 43 (6) 990-996
  CrossrefPubMedGoogle Scholar
• 31 D'Amico G, Luca A, Morabito A, Miraglia R, D'Amico M. Uncovered transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis. Gastroenterology 2005; 129 (4) 1282-1293
  CrossrefPubMedGoogle Scholar
• 32 Thalheimer U, Leandro G, Samonakis DN , et al. TIPS for refractory ascites: a single-centre experience. J Gastroenterol 2009; 44 (10) 1089-1095
  CrossrefPubMedGoogle Scholar
• 33 Harrod-Kim P, Saad WE, Waldman D. Predictors of early mortality after transjugular intrahepatic portosystemic shunt creation for the treatment of refractory ascites. J Vasc Interv Radiol 2006; 17 (10) 1605-1610
  CrossrefPubMedGoogle Scholar
• 34 Sanyal AJ. Pros and cons of TIPS for refractory ascites. J Hepatol 2005; 43 (6) 924-925
  CrossrefPubMedGoogle Scholar
• 35 Bureau C, Métivier S, D'Amico M , et al. Serum bilirubin and platelet count: a simple predictive model for survival in patients with refractory ascites treated by TIPS. J Hepatol 2011; 54 (5) 901-907
  CrossrefPubMedGoogle Scholar
• 36 Wu X, Ding W, Cao J, Fan X, Li J. Clinical outcome using the fluency stent graft for transjugular intrahepatic portosystemic shunt in patients with portal hypertension. Am Surg 2013; 79 (3) 305-312
  PubMedGoogle Scholar
• 37 Dhanasekaran R, Gonzales P, West JK , et al. Abstract no. 82: transjugular intrahepatic portosystemic shunt (TIPS) for refractory ascites. J Vasc Interv Radiol 2010; 21: S33
  PubMedGoogle Scholar
• 38 Guevara M, Baccaro ME, Ríos J , et al. Risk factors for hepatic encephalopathy in patients with cirrhosis and refractory ascites: relevance of serum sodium concentration. Liver Int 2010; 30 (8) 1137-1142
  CrossrefPubMedGoogle Scholar
• 39 Tripathi D, Redhead D. Transjugular intrahepatic portosystemic stent-shunt: technical factors and new developments. Eur J Gastroenterol Hepatol 2006; 18 (11) 1127-1133
  PubMedGoogle Scholar
• 40 Bhogal HK, Sanyal AJ. Using transjugular intrahepatic portosystemic shunts for complications of cirrhosis. Clin Gastroenterol Hepatol 2011; 9 (11) 936-946 , quiz e123
  CrossrefPubMedGoogle Scholar
• 41 Boyer TD, Haskal ZJ ; American Association for the Study of Liver Diseases. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension: update 2009. Hepatology 2010; 51 (1) 306
  CrossrefPubMedGoogle Scholar
• 42 Bureau C, Garcia-Pagan JC, Otal P , et al. Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: results of a randomized study. Gastroenterology 2004; 126 (2) 469-475
  CrossrefPubMedGoogle Scholar
• 43 Bureau C, Pagan JCG, Layrargues GP , et al. Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts: long-term results of a randomized multicentre study. Liver Int 2007; 27 (6) 742-747
  CrossrefPubMedGoogle Scholar
• 44 Clark W, Golkar F, Luberice K , et al. Uncovering the truth about covered stents: is there a difference between covered versus uncovered stents with transjugular intrahepatic portosystemic shunts?. Am J Surg 2011; 202 (5) 561-564
  CrossrefPubMedGoogle Scholar
• 45 Tripathi D, Ferguson J, Barkell H , et al. Improved clinical outcome with transjugular intrahepatic portosystemic stent-shunt utilizing polytetrafluoroethylene-covered stents. Eur J Gastroenterol Hepatol 2006; 18 (3) 225-232
  CrossrefPubMedGoogle Scholar
• 46 Bureau C. Covered stents for TIPS: are all problems solved?. Eur J Gastroenterol Hepatol 2006; 18 (6) 581-583
  CrossrefPubMedGoogle Scholar
• 47 Membreno F, Baez AL, Pandula R, Walser E, Lau DTY. Differences in long-term survival after transjugular intrahepatic portosystemic shunt for refractory ascites and variceal bleed. J Gastroenterol Hepatol 2005; 20 (3) 474-481
  CrossrefPubMedGoogle Scholar
• 48 Ockenga J, Ockenga T, Kroencke T , et al. 222 cost analysis of E-PTFE covered tips stents compared to bare stents. J Hepatol 2004; 40: 71
  PubMedGoogle Scholar
• 49 Morrow CS, Kantor M, Armen RN. Hepatic hydrothorax. Ann Intern Med 1958; 49 (1) 193-203
  CrossrefPubMedGoogle Scholar
• 50 Gordon FD, Anastopoulos HT, Crenshaw W , et al. The successful treatment of symptomatic, refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt. Hepatology 1997; 25 (6) 1366-1369
  CrossrefPubMedGoogle Scholar
• 51 Islam N, Ali S, Kabir H. Hepatic hydrothorax. Br J Dis Chest 1965; 59 (4) 222-227
  CrossrefPubMedGoogle Scholar
• 52 Sherlock S, Dooley J. Diseases of the Liver and Biliary System. Chichester, GBR: Wiley; 2008
  CrossrefGoogle Scholar
• 53 Cardenas A, Kelleher T, Chopra S. Review article: hepatic hydrothorax. Aliment Pharmacol Ther 2004; 20 (3) 271-279
  CrossrefPubMedGoogle Scholar
• 54 Rubinstein D, McInnes IE, Dudley FJ. Hepatic hydrothorax in the absence of clinical ascites: diagnosis and management. Gastroenterology 1985; 88 (1 Pt 1): 188-191
  CrossrefPubMedGoogle Scholar
• 55 Siegerstetter V, Deibert P, Ochs A, Olschewski M, Blum HE, Rössle M. Treatment of refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt: long-term results in 40 patients. Eur J Gastroenterol Hepatol 2001; 13 (5) 529-534
  CrossrefPubMedGoogle Scholar
• 56 Andrade RJ, Martin-Palanca A, Fraile JM , et al. Transjugular intrahepatic portosystemic shunt for the management of hepatic hydrothorax in the absence of ascites. J Clin Gastroenterol 1996; 22 (4) 305-307
  CrossrefPubMedGoogle Scholar
• 57 Saad WE, Wagner CC, Lippert A , et al. Protective value of TIPS against the development of hydrothorax/ascites and upper gastrointestinal bleeding after balloon-occluded retrograde transvenous obliteration (BRTO). Am J Gastroenterol 2013; 108 (10) 1612-1619
  CrossrefPubMedGoogle Scholar
• 58 Urbani L, Catalano G, Cioni R , et al. Management of massive and persistent ascites and/or hydrothorax after liver transplantation. Transplant Proc 2003; 35 (4) 1473-1475
  CrossrefPubMedGoogle Scholar
• 59 Abouljoud M, Yoshida A, Kim D , et al. Transjugular intrahepatic portosystemic shunts for refractory ascites after liver transplantation. Transplant Proc 2005; 37 (2) 1248-1250
  CrossrefPubMedGoogle Scholar
• 60 Saad WEA, Davies MG, Lee DE , et al. Transjugular intrahepatic portosystemic shunt in a living donor left lateral segment liver transplant recipient: technical considerations. J Vasc Interv Radiol 2005; 16 (6) 873-877
  CrossrefPubMedGoogle Scholar
• 61 Lerut JP, Laterre PF, Goffette P , et al. Transjugular intrahepatic portosystemic shunt and liver transplantation. Transpl Int 1996; 9 (4) 370-375
  CrossrefPubMedGoogle Scholar
• 62 Somberg KA, Lombardero MS, Lawlor SM , et al; The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Liver Transplantation Database. A controlled analysis of the transjugular intrahepatic portosystemic shunt in liver transplant recipients. Transplantation 1997; 63 (8) 1074-1079
  CrossrefPubMedGoogle Scholar
• 63 Choi DX, Jain AB, Orloff MS. Utility of transjugular intrahepatic portosystemic shunts in liver-transplant recipients. J Am Coll Surg 2009; 208 (4) 539-546
  CrossrefPubMedGoogle Scholar
• 64 Saad WEA, Darwish WM, Davies MG , et al. Transjugular intrahepatic portosystemic shunts in liver transplant recipients: technical analysis and clinical outcome. AJR Am J Roentgenol 2013; 200 (1) 210-218
  CrossrefPubMedGoogle Scholar